| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |